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CD8þ cytotoxic T lymphocytes (CTL) can be effective at controlling HIV-1 in humans and SIV in macaques, but their
utility is partly offset by mutational escape. The kinetics of CTL escape and reversion of escape mutant viruses upon
transmission to MHC-mismatched hosts can help us understand CTL-mediated viral control and the fitness cost
extracted by immune escape mutation. Traditional methods for following CTL escape and reversion are, however,
insensitive to minor viral quasispecies. We developed sensitive quantitative real-time PCR assays to track the viral load
of SIV Gag164–172 KP9 wild-type (WT) and escape mutant (EM) variants in pigtail macaques. Rapid outgrowth of EM
virus occurs during the first few weeks of infection. However, the rate of escape plateaued soon after, revealing a
prolonged persistence of WT viremia not detectable by standard cloning and sequencing methods. The rate of escape
of KP9 correlated with levels of vaccine-primed KP9-specific CD8þT cells present at that time. Similarly, when non-KP9
responder (lacking the restricting Mane-A*10 allele) macaques were infected with SHIVmn229 stock containing a mixture
of EM and WT virus, rapid reversion to WT was observed over the first 2 weeks following infection. However, the rate of
reversion to WT slowed dramatically over the first month of infection. The serial quantitation of escape mutant viruses
evolving during SIV infection shows that rapid dynamics of immune escape and reversion can be observed in early
infection, particularly when CD8 T cells are primed by vaccination. However, these early rapid rates of escape and
reversion are transient and followed by a significant slowing in these rates later during infection, highlighting that the
rate of escape is significantly influenced by the timing of its occurrence.
Citation: Loh L, Petravic J, Batten CJ, Davenport MP, Kent SJ (2008) Vaccination and timing influence SIV immune escape viral dynamics in vivo. PLoS Pathog 4(1): e12. doi:10.
1371/journal.ppat.0040012
Introduction
CD8þ cytotoxic T lymphocyte (CTL) responses during
acute HIV-1 and simian immunodeﬁciency virus (SIV)
infection in humans and macaques, respectively, correlate
with effective control of acute viremia [1–4]. CTL responses
to both HIV-1 and SIV are, however, partially undermined by
the evolution of viral escape [5–10]. Many CTL escape
mutations evolve to select a single common escape motif,
including the Mane-A*10-restricted KP9 SIV Gag epitope in
pigtail macaques, which selects the K165R mutation to escape
this response [11]. Our studies to date have suggested that
CTL escape at KP9 can be rapid during acute infection, and
completed within 1–2 weeks [11].
Reversion of CTL EM variants upon transmission to MHC-
mismatched hosts have also been widely documented in both
human and macaque settings [12–14]. These studies imply a
signiﬁcant ﬁtness cost to the evolution of some Gag CTL
escape mutations. Rapid reversion of the K165R escape
mutant (EM) KP9 virus is observed in Mane-A*10 negative
pigtail macaques infected with EM challenge stock SHIVmn229,
suggesting a signiﬁcant ﬁtness cost of the K165R mutation
[11].
To further elucidate CTL escape and reversion kinetics, we
recently studied the in vivo effectiveness of different SIV Gag–
restricted T cell responses in pigtail macaques [15]. Variable
rates of escape and reversion occur across different Gag
epitopes, implying that CTL effectiveness is also variable.
These studies, like many others, used the traditional approach
of cloning and sequencing a limited number of individual
viruses (generally 10–20) to derive crude escape and reversion
kinetics. Although widely accepted, this method is labour
intensive and insensitive to the detection of subdominant
viral quasispecies. For example, even where the viral load of
an escape mutant virus is high (e.g. 10
5 copies/ml), if the wild-
type (WT) virus is 10-fold higher (e.g. 10
6 copies/ml), the EM
virus is difﬁcult to either detect or accurately quantitate by
cloning and sequencing unless many clones are sequenced. It
is thus very difﬁcult to track CTL escape and reversion
beyond the initial selection phase without more sensitive
technologies.
Quantitative real-time PCR (qRT-PCR) assays to track CTL
escape mutations viral loads are needed to more accurately
study the evolution of immune escape. Discrimination of WT
from EM virus where a single base pair is altered would prove
difﬁcult using standard sequence-speciﬁc primers in PCR
since WT primers may cross-react with the EM target with
reasonable efﬁciency. However, a number of recent technical
advances in sequence detection chemistries make this a more
feasible task. Probes conjugated to a DNA Minor groove
binding (MGB) moieties improve increase the stability and
sensitivity for complementary sequence [16]. Similarly,
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added to probes and primers. Locked nucleic acids are DNA
analogs with a C49-O2-methlene bridge incorporation in the
sugar of a nucleotide. This modiﬁcation allows for greater
stability and speciﬁcity for complementary sequence [17,18].
Assays utilising real-time PCR technology and DNA probes
for sequence-speciﬁc detection and measurement of common
single nucleotide drug resistance mutations in HIV-1 in-
fection have been developed [19]. These assays detected
minor but clinically important levels of drug resistant virus
variants typically missed by sequencing technologies. Peyerl
and colleagues designed a molecular beacon-based assay to
quantify common quasispecies in the Mamu-A*01-restricted
SIV Gag CM9 CTL epitope [20]. However, this assay had a
limited detection level of 5310
2 copies/ml of EM virus in 10
4
copies/ml of total virus. This level of sensitivity can be
problematic for samples assayed during acute infection where
total virus can be in excess of 10
6 copies and the minor
quasispecies may only be present at 10
2-10
3 copies.
We report here the development of qRT-PCR assays
utilising MGB-DNA probe and LNA-modiﬁed primer tech-
nologies to elucidate the ﬁner kinetics of CTL escape and
reversion. These assays sensitively detect minor viral quasis-
pecies and allow comparative quantiﬁcation of WT and EM
viruses. We used these assays to reﬁne our understanding of
the evolution of KP9 SIV Gag CTL escape mutant viruses in
pigtail macaques.
Methods
Macaques, Vaccinations, and Viruses
Experiments on outbred pigtail macaques (Macaca nemestri-
na) were approved by the University of Melbourne and
CSIRO livestock industries Animal Ethics Committees. Pigtail
macaques were MHC typed by reference strand-mediated
conformational analysis for the Mane-A*10 allele which
present SIV Gag epitope KP9 [21,22].
CTL escape and reversion kinetics was studied in 12 pigtail
macaques (8 Mane-A*10þ,4Mane-A*10 negative) in previously
reported studies. Six Mane-A*10þ macaques were participat-
ing in DNA prime/recombinant fowlpoxvirus (rFPV) boost
vaccine studies involving a viral challenge with either R5-
tropic SHIVSF162P3 (animals 4292, 4246 [11,23]) or X4-tropic
SHIVmn229 (vaccinated animals 6276, 5614, unprimed animals
6167, 5712 [24,25]). Further analyses of CTL escape were
conducted in 2 naive Mane-A*10þ pigtail macaque infected
with R5-tropic SIVmac251 (animal 5175, 5284 [26]). Reversion
of the KP9 EM stock SHIVmn229 was studied in 4 Mane-A*10
negative pigtail macaques (4194, 4301, 1.1705, H20 [27]). We
had previously studied escape and reversion at the KP9
epitope by extracting SHIV RNA from plasma and amplifying
and sequencing cDNAs as previously described [11].
Development of qRT- PCR for EM and WT Virus at KP9
Epitope
To quantify and validate the SIV Gag KP9 qRT-PCR, RNA
standards were ﬁrst constructed from WT and EM virus
sequence. In short, pDNA clones previously sequenced at the
SIV Gag KP9 were selected for EM and WT RNA standards,
after conﬁrmation from re-sequencing of the speciﬁed
region. Prior to transcription of in vitro RNA, pDNA was
linearized with the restriction endonuclease SpeI (Promega).
In vitro RNA was transcribed using the ribomax T7 promoter
kit (Promega) according to manufacturer’s instructions.
Following transcription, RNA was puriﬁed with the QIA
RNA MinElute Kit according to manufacturer’s instructions
(Qiagen). Puriﬁed RNA was electrophoresed on a 1.5%
agarose gel to check for the presence of correct transcript.
Purity and concentration of RNA was derived to calculate
RNA total copy number from UV spectrophotometry
absorbance readings at 260nm using Ultrospec 3100Pro UV/
Vis spectrophotometer (Amersham Biosciences).
To quantify WT and EM viral loads, standard curves were
produced by reverse transcribing 10
9 copies of RNA
standard and diluting cDNA 10-fold (10
7-10
1 copies) in
nuclease-free water to produce WT and EM cDNA standards
for analysis. RNA was extracted from serial plasma samples
isolated from infected pigtail macaques using a QIAmp
Viral RNA mini kit (Qiagen). 10ll of RNA was subjected to
two-step qRT-PCR. The ﬁrst step involved reverse tran-
scription of RNA in a 30 ll reaction carried out as follows:
10ll of RNA was added to a PCR mix containing: 103 PCR
Buffer II (ABI), 103 PCR Buffer A, 5mM of MgCl2 (Promega),
10lM of random hexamers, 0.5mM of each dNTP (Promega),
20U of RNasin (Promega), and 20U of SuperScript III RNase
H- reverse transcriptase (Invitrogen). The cycling conditions
were: 258C for 15 min, 428C for 40 min, and 758C for 5 min,
using GeneAmp 9700 PCR thermal cycler (ABI) or Reaplex
4
(Eppendorf). 50ll qRT-PCR reactions were achieved by the
addition of 30llo fc D N At o2 0 llo fq R T - P C Rm i x
containing: 17ll of 2x TaqMan universal mastermix
(ABI), 100nM of Minor Groove Binding (MGB)-Gag-KP9: 59
6FAM- CCTGGCACTACTTCT- MGBNFQ 39 where NFQ ¼
Non-ﬂuorescent quencher (ABI), 400nM of reverse primer
No. 179: 59 CCTTCTGACAGTGCCTGAA 39 for KP9, 400nM
of WT forward primer or EM forward primer was also
added to each PCR reaction. The WT primers for KP9 was
No.172 59 GGþGTAAAATTþGATAþGAGGAAAAGAþA3 9 (þ
precedes LNA-modiﬁed bases; mutated codons are denoted
by underlined bases). The forward primers for EM KP9
was No.174: 59 GGþGTAAAATTþGATAþGAGGAAAAGAþG
39. To validate the total virus (WT þEM KP9) quantiﬁed
an additional SIV Gag forward primer #230 59
GGþGTAAAATTþGATAþGAGGAAAAGA 39 which ampli-
ﬁes both targets was combined with primer #179 and the
MGB-probe to separately quantify total virus.
The cycling conditions were as follows: 508C for 2 min, 958C
for 10 min, followed by 45 cycles of: 958C for 15 sec, 638C for
60 sec, using an ABI Prism 7700 sequence detection system
PCR thermal cycler or an Eppendorf Realplex
4 cycler.
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Author Summary
Immune escape from AIDS virus–specific cellular immunity is
common. The driving forces behind how quickly cellular immunity
forces escape are poorly understood. We developed a novel assay
for a common immune escape variant of SIV in macaques. This
allowed us to sensitively track the rates of immune escape even
when levels of escape mutant or wild-type virus were low. We found
that prior immunization of macaques resulted in very rapid immune
escape during acute infection. However, when escape starts to occur
later, during chronic infection, the rate of immune escape is much
more gradual. Thus, both prior vaccination and timing influence the
rates of immune escape and provide a fuller picture of the
effectiveness of T cell immunity to HIV.Analysis was performed using SDS applications version 1.9
(ABI) or Eppendorf Realplex
4 software. Baselines were set 2
cycles earlier than real reported ﬂuorescence and threshold
value was determined by setting threshold bar within the
linear data phase. Samples amplifying after 40 cycles were
regarded as negative, and correspond to , 1.5-Log10 SHIV/
SIV RNA copies/ml of plasma (threshold value of quantiﬁca-
tion).
Characterization of Reversion and Escape Rates
We deﬁne reversion rate as the absolute difference in
growth rates between the wild-type (W) and mutant (M) in a
given time interval [11]. If fW(t) is the fraction of wild-type and
fM(t) is the fraction of escape mutant clones at time t, we can
calculate the time-dependent reversion rate R from the
proportions of clones of each type at the end points ts and te
of the time interval,
Rðts;teÞ¼
ln½ fWðteÞ=fMðteÞ    ln½ fWðtsÞ=fMðtsÞ 
te   ts
: ð1Þ
Negative reversion rate implies that the mutant has a
growth advantage over wild-type.
Escape rate E is deﬁned as the difference of growth rates of
the escape mutant and wild-type,
Eðts;teÞ¼
ln½ fMðteÞ=fWðteÞ    ln½ fMðtsÞ=fWðtsÞ 
te   ts
; ð2Þ
so that the negative escape rate implies that the fraction of
wild-type increases in the given time interval. The expressions
for reversion and escape rates assume exponential growth/
decay of viral load within the time interval. The justiﬁcation
for this assumption is that, when viral load changes rapidly
between two time points, its time dependence is better
described by an exponential than by a linear function. When
the change is slow, linear and exponential interpolations give
almost the same results (not shown). Correlations between
reversion / escape rate and other parameters were performed
using non-parametric (Spearman) correlations.
Results
SIV Gag KP9 qRT-PCR Sensitively Quantitates Minor Viral
Quasispecies
To more sensitively track CTL EM and WT viremia, we
developed and analyzed a series of qRT-PCT assays on plasma
viral RNA. We initially studied labelled Taqman probes
speciﬁc for either EM or WT sequence as previously reported
[20], but found the use of LNA-modiﬁed sequence-speciﬁc
forward primers much more sensitive and speciﬁc (not
shown). The combination of LNA-modiﬁed forward primers
speciﬁc for WT or EM viruses at the KP9 Gag epitope with
MGB-DNA probes to quantify either target was validated as
an alternative method to labour intensive cloning and
sequencing of viral populations (Figure 1A). The SIV Gag
KP9 qRT-PCR assays were validated on WT and EM RNA
standards created from in vitro transcription of plasmid DNA.
Primers were validated for speciﬁcity by adding the WT
forward primer to serial 10-fold dilutions of EM RNA
standards; the inverse was performed with the EM primer.
The KP9 forward primer was only very minimally cross-
reactive in the presence of massively excess target (. 2 310
5
copies) and even then the ampliﬁcation of mismatched target
was  10 cycles after that of matched target (Table 1).
To more rigorously examine the speciﬁcity and sensitivity
of qRT-PCR, a series of mixed dilutions of WT and EM RNA
standards were prepared to mimic the mixed target ratios
that may occur during SIV/SHIV infection. The cycle thresh-
old (Ct) value (cycle number at which ampliﬁcation cross
above background ﬂuorescence) was then compared to
ampliﬁcation of WT target without competing target (EM)
(Table 1). Similar results were observed with the EM forward
primers. The KP9 qRT-PCR assays detected up to 10 copies of
WT target in an excess of 10
6 EM copies, although the Ct
value for detection of mixed WT KP9 was 2.4 cycles earlier
than detection of 10 copies of WT alone. To ensure that this
was not due cross reactivity of the WT primer, the PCR
product was bulk sequenced, and the chromatogram con-
ﬁrmed no mixed base at the position of the escape mutation.
We then compared the proportions of KP9 WT and EM virus
by qRT-PCR assay in a large series of pigtail macaque plasma
samples (46 samples) that had previously undergone cloning
and sequencing with varying levels of WT and EM clones. The
assays were tightly correlated (r
2 ¼ 0.94, p ,0.0001, Figure
1B). We further validated the assay by comparing the sum of
the WT and EM VL with total VL detected using a
quantiﬁcation forward primer outside the K165R mutation
on 129 plasma samples. The total viral loads detected by both
methods were tightly correlated (Figure 1C).
Kinetics of Escape Mutant Viremia
We previously studied CTL escape at KP9 in DNA and
rFPV-immunized Mane-A*10þ pigtail macaques infected with
SHIVSF162P3, a challenge stock that contains WT SIVmac239 gag
[11,23]. The kinetics of escape derived from cloning and
sequencing of plasma viral cDNA indicated that rapid escape
occurred during acute infection. To further deﬁne the ﬁne
kinetics of escape and validate the in vivo utility of our novel
assay, we applied the KP9 qRT-PCR assay on a time course of
RNA samples extracted from two Mane-A*10þ macaques.
From qRT-PCR we can measure EM and WT viral loads
comparatively. Wild-type virus decays rapidly between 2–3.5
weeks after infection in both animals (Figure 2A and 2B). The
sensitivity of qRT-PCR is demonstrated in animal 4292, where
minor amounts of EM virus starts to become detectable
during the peak of viremia when WT virus is 2-Log10 greater
than EM virus. These minor populations of EM virus are
difﬁcult to detect by cloning and sequencing (Figure 2A and
2C). Similarly, minor WT virus populations are detectable
well after the peak of infection (week 4), at a time when escape
appears ‘‘complete’’ by cloning and sequencing (Figure 2A
and 2C). When plotted as a proportion of WT virus, in vivo
kinetics of escape in acute infection are very similar between
the qRT-PCR assay and cloning/sequencing technologies
(Figure 2C). However, qRT-PCR allows estimation of escape
rate over a much longer period post-infection. This shows a
considerable slowing in the rate of escape after the ﬁrst ;4
weeks on infection, a phenomenon not measurable using
standard cloning and sequencing approaches.
Rates of Reversion of Escape Mutant Virus
Escape mutant viruses usually incur some reduced level of
replicative ﬁtness as a result of the escape mutation (the
‘‘ﬁtness cost of escape’’); this is most clearly demonstrated
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MHC-mismatched hosts [11,12,13,28]. We previously studied
reversion of WT KP9 virus in Mane-A*10þ macaques
challenged with the EM challenge virus SHIVmn229. This virus
is derived from a SHIVHXB2 stock passaged through Mane-
A*10þpigtail macaques [11]. The SHIVmn229 stock was 90.9%
(40/44 clones) K165R EM virus and 9.1% (4/44 clones) WT
virus by cloning and sequencing. The challenge virus stock
was 11.2% WT by our qRT-PCR. Reversion of the EM
SHIVmn229 stock was rapid in all 4 Mane-A*10 negative
animals studied. The decay of EM virus occurred after peak of
viremia and the EM virus was present only at minor or
undetectable levels by 8 weeks after infection (Figure 3).
The rate of reversion to WT virus estimated using qRT-
PCR was very similar to that observed using conventional
cloning and sequencing during the ﬁrst 2 weeks of infection
(mean reversion rate of 0.38 for day for cloning and
sequencing [11], and 0.35 per day for qRT-PCR). However,
after this time the rate of reversion to WT slowed signiﬁcantly
(Figures 3 and 4), and signiﬁcant levels of EM virus persisted
for several weeks. It has previously been noted that the
maximal reversion rate will only be observed when total viral
load is in exponential growth, and that overall viral dynamics
will determine the observed rate of reversion [11,29].
Consistent with this, the rate of reversion was positively
correlated with the overall viral growth rate (Figure 4F, r ¼
0.50), approaching statistical signiﬁcance (p ¼ 0.06). This
suggests that, like the rate of escape described above, the rate
of reversion slows dramatically after the ﬁrst few weeks of
infection.
Transient Reversions and Re-Escape Timing Is Influenced
by Prior Vaccinations
Reversion and re-escape of EM virus in MHC-matched
hosts has been correlated with the expansion of epitope-
speciﬁc CTL [25,30]. Our group recently demonstrated that
in animals responding to the KP9 epitope, infection with a
mix of WT and EM virus results in an early phase of reversion
to WT (presumably due to a delay in the induction of the CTL
response [31]), followed by a later phase of immune escape
due to CTL mediated killing of WT infected cells. The extent
of this early reversion is inversely correlated with the level of
vaccine-induced KP9-speciﬁc CTLs in EM KP9 SHIVmn229-
infected Mane-A*10þ pigtail macaques [25]. However, the
timing and kinetics of reversion and re-escape were assessed
only at a few time points by insensitive cloning and
sequencing techniques. We hypothesised that the very limited
dynamic range of cloning and sequencing probably under-
estimates the degree to which WT virus is controlled by prior
vaccination.
SIV Gag KP9 qRT-PCR analysis of two vaccinated and two
control animals without prior induction of KP9-speciﬁc T
cells yielded contrasting results (Figure 5). Animals 6276 and
5614 were vaccinated with DNA/FPV prime/boost vaccines
Figure 1. SIV Gag164–172 KP9 qRT-PCR Assay Schematic and Validation
(A) Wild-type (WT)-specific locked nucleic acid (LNA) primer sequence highlighted in dark grey, escape mutant–specific sequence highlighted in light
grey. Bold underlined nucleotides represent mutations within epitopes. DNA reverse primer and FAM-labeled minor groove binding-DNA probe allow
quantification of both WT and EM target.
(B) Validation of proportions of EM and WT virus at KP9 comparing qRT-PCR to cloning and sequencing on 46 plasma samples.
(C) Validation of the sum of the EM and WT VL detected by qRT-PCR compared to total VL detected using a quantification primer outside the KP9
epitope on 129 plasma samples.
doi:10.1371/journal.ppat.0040012.g001
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CTL Escape Mutant DynamicsFigure 2. Minor Populations of Wild-Type KP9 Virus Can Be Detected by
qRT-PCR during Chronic Infection
SIV Gag KP9 qRT-PCR analysis was performed on serial RNA samples
extracted from plasma from Mane-A*10 pigtail macaques (A) 4292 and
(B) 4246 infected with SHIVSF162P3. Wild-type and escape mutant KP9
viruses are represented by closed squares and open triangles,
respectively, throughout. Cloning and sequencing (open squares) was
compared to qRT-PCR (closed squares) to establish the proportions of
wild-type KP9 virus in animal 4292 (C). A mean of 25 clones were
sequenced across KP9 for each time point.
doi:10.1371/journal.ppat.0040012.g002
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CTL Escape Mutant Dynamicsand DNA vaccination only, respectively, and had detectable
levels of KP9-speciﬁc CD8 T cells at infection (0.06% and
0.04% of CD8 T cells, respectively, by KP9/MHC-tetramer)
that expanded to high levels after challenge (peaking at up to
42% 2 weeks after challenge, Figure 5A [25]). Both WT and
EM KP9 virus expanded very early after SHIVmn229 inocu-
lation up to the peak of viremia (week 2 post-infection);
however, this is followed by an abrupt loss of WT virus to low
levels by week 3 where EM virus dominates as KP9-speciﬁc T
cells expand. Furthermore, the striking difference in absolute
quantities of EM and WT are 2.5-Log10 or greater week 3
post-infection, and this minor population of WT virus is
unlikely to be detectable by cloning and sequencing.
The situation is very different in un-primed animals 5712
and 6167. These animals had 0.00% KP9-speciﬁc T cells at the
time of challenge, and only up to 0.2% by 2 weeks after
challenge (Figure 5B). The WT virus decay is gradual, and this
is most clearly observed at week 3 where in un-primed animals
WT and EM virus are co-dominant, and the viral load is ;5
Log10 (Figure 5B). These ﬁndings illustrate the extent to which
prior vaccination impacts the rates of killing of WT viremia.
The rates of both reversion and escape are fastest during
early infection, and then slow by 5 weeks post-infection. In
the vaccinated animals, an initial rapid burst of escape was
observed around day 10–20, followed by a signiﬁcant slowing
in escape. This paralleled the levels of KP9-speciﬁc CTLs
(Figure 6A–6E). WT virus was still detectable out to week 11
after infection at low levels (;1,000-fold lower than EM). By
contrast, in the animals without prior induction of KP9-
speciﬁc T cells by vaccination, escape did not occur until later
(day 20 onwards). When escape did occur it was at a slower
rate, similar to the rate observed in the vaccinated animals at
these later times.
The pattern of rapid early escape followed by a signiﬁcant
slowing is consistent with the rapid early reversion seen above
and suggests again an association with overall viral dynamics,
with rapid escape at periods of high overall viral growth and
decay. However, the rate of escape is also thought to be
determined largely by the magnitude of the CD8þ T cell
pressure on the virus (which also varies during acute infection
(Figure 6C)). Consistent with this, the rate of escape was
signiﬁcantly correlated with KP9-speciﬁc CD8þT cell levels (r
¼ 0.41, p ¼ 0.01, Figure 6F).
Slow Escape during Chronic SIV Infection
Our initial studies demonstrated a very rapid rate of escape
at the KP9 SIV Gag CTL epitope during acute infection,
followed by a slower rate of escape. We hypothesised that
when escape begins later during chronic infection, it may
have slower kinetics since the overall viral expansion rates are
negligible at this time. To further study the concept of slow
escape during late infection, we analysed serial plasma
samples from naı ¨ve Mane-A*10þ macaques infected with WT
SIVmac251 that we had previously noticed appeared to have
Figure 3. In Vivo Reversion of KP9 Escape Mutant Virus
The kinetics of reversion at SIV Gag KP9 was assessed by qRT-PCR from serial RNA samples extracted from plasma in 4 Mane-A*10 negative pigtail
macaques infected with the EM KP9 SHIVmn229 reversion (11.2% WT KP9 by qRT-PCR).
doi:10.1371/journal.ppat.0040012.g003
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CTL Escape Mutant Dynamicsslower kinetics of escape by a limited amount of cloning and
sequencing [26]. The qRT-PCR assay conﬁrmed a slow
replacement of WT with EM virus over 8 weeks (weeks 5–13
after infection, Figure 7A). This is consistent with stable
overall viral loads during this time and low rates of escape
(Figure 7B, open blue circles)
Discussion
CTL responses drive mutational escape in both HIV-1 and
SIV infection [5,7,8,9,10,11,32]. Previous analyses of CTL
escape and reversion of EM viruses relies on cloning and
sequencing limited numbers of cDNA clones; this method is
expensive, labour intensive and also insensitive to viral
quasispecies of low frequency. Higher-throughput assays with
larger dynamic ranges are required to more accurately
monitor later phases of mutational escape and reversion.
We show that sensitive qRT-PCR assays can be developed to
quantify minor viral quasispecies utilising MGB-DNA probe
and LNA-modiﬁed primer technologies. The qRT-PCRs can
detect greater than a 10
4 virus copy difference between WT
and EM viruses, which was validated both in vitro and in vivo.
The dynamic range of discrimination of this assay surpassed
Figure 4. Rapid Early Reversion of KP9 from Escape Mutant to Wild-Type Virus
The levels of WT and EM virus in a representative animal (#4301) are shown (A), as is the fraction of EM and WT virus over time (B). The average growth
rates of WT (black) and EM (red) virus in different time intervals are calculated from the viral loads in (C), and the rate of reversion to WT is shown in (D).
Growth rates could not be evaluated during the first week because the viral loads at day 0 were below detection (grey rectangle in [C]), but reversion
rate was calculated from the known percentages of EM and WT in the inoculum. A comparison of the variation of reversion rate with time is shown for
the different animals (E), and the correlation between reversion rate and total virus growth rate (F).
doi:10.1371/journal.ppat.0040012.g004
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CTL Escape Mutant Dynamicsour own and other [20] attempts using molecular beacon
technologies.
We studied the longitudinal kinetics of escape in individual
animals by measuring the viral load of EM and WT virus at
KP9 over time. The rate of reversion of EM to WT virus was
rapid early, followed by a marked slowing in reversion rate,
consistent with previous predictions that the maximum
reversion would only be observed during exponential viral
growth. This study only monitored reversion in circum-
stances where both WT and EM were present in the initial
inoculum. However, it suggests that where WT virus is not
present in the inoculum and arises instead through mutation
of EM virus later during the course of infection, we would
expect to observe slower rates of reversion even for the same
overall difference in viral ﬁtness.
Similarly, we studied the rate of escape from immune
pressure in three circumstances (Figure 7B): (i) where EM
arose due to mutation of WT virus during acute infection
with SHIVSF162P3, (ii) where both EM and WT were present in
the initial inoculum (with SHIVmn229) and early reversion to
WT was followed by escape, and (iii) where EM arose due to
mutation of WT late during infection with SIVmac251.
Although different parental viral strains were used in these
studies, comparison of the rates of escape across the models
suggests a similar pattern to that observed in reversion:
signiﬁcantly higher rates of escape in early infection, which
tended to stabilise later. Notably, where escape only occurred
late (in the unvaccinated SIVmac251 and SHIVmn229 infected
animals), the rate of escape was similar to the rate observed in
the vaccinated animals at the same time (even though the
vaccinated animals had earlier shown a burst of rapid early
escape). It is difﬁcult to determine in this case whether the
slower rates of escape later in infection were determined by
viral dynamics or KP9-speciﬁc CD8þ T cell dynamics, since
the number of KP9-speciﬁc cells followed a similar trend to
the escape rate, and the rate of escape was signiﬁcantly
correlated with KP9-speciﬁc CTL numbers (Figure 6F).
Another possibility is that CTLs lose some functionality
during chronic infection, resulting in less selective pressure
during escape. However, it appears that vaccination was
associated with earlier and more rapid escape, and ultimately
also WT virus was suppressed to lower levels compared to EM.
Figure 5. Transient Reversions and Re-Escape Timing Is Influenced by Prior Vaccination and Levels of KP9-Specific CTL
Wild-type (closed squares) and escape mutant (open triangles) KP9 was measured by SIV Gag KP9 qRT-PCR to compare the kinetics of transient
reversion and re-escape in four Mane-A*10þpigtail macaques; 6276 and 5614 were vaccinated with DNA/FPV prime/boost vaccines (A), 5712 and 6167
were the control animals and had no prior induction of KP9-specific T cells (B). Levels of KP9-specific CD8 T cells detected by the Mane-A*10/KP9
tetramer at 2 weeks after challenge for each animal are shown as an inset. The y-axis is the KP9 tetramer and the x-axis is CD8. Cells shown are gated
CD3þ lymphocytes.
doi:10.1371/journal.ppat.0040012.g005
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CTL Escape Mutant DynamicsEffective vaccination clearly modulates the evolution of
mutational escape and reversion. We recently showed that
vaccination induces KP9-speciﬁc T cells that control rever-
sion of EM viruses in MHC-matched pigtail macaques [25]. In
this study, where WT and EM KP9 viremia can be measured
compared by sensitive qRT-PCR, the effect of prior vacci-
nations is emphatically demonstrated. A marked 3-Log10 loss
in WT viral load occurs within 3 weeks of infection in
vaccinated animals; vaccination is effectively controlling the
WT virus (but not, of course, the EM virus).
A number of recent studies have measured the rate of
selection of WT and EM virus as a way of estimating the
strength of immune pressure and/or ﬁtness cost of escape
mutation [11,25,33]. However, previous studies, including our
own, have not taken into account the effects of the time when
escape is ﬁrst detected on the observed rate of escape. For
example, in our previous study we observed the rate of
selection of EM virus in SHIVmn229 and SHIVsf162 infected
animals, where escape occurred in the ﬁrst few weeks of
infection (Figure 7B) [11,25]. As discussed above, the rate of
escape was high in the ﬁrst few weeks of infection, but rapidly
slowed by 1–2 months after infection. By contrast, during
SIVmac251 infection, escape was not observed until later in
infection, starting after the ﬁrst month. A direct comparison
Figure 6. Early Reversion and Re-Escape Rates at the KP9 Epitope
The levels of KP9 wild-type and escape mutant in a representative animal (#6276) following infection with the SHIVmn229 virus (containing 11.2% WT and
88.8% EM virus) (A). The fraction (B) and growth rates (C) of WT and EM virus over time are also shown. The rate of escape (D) is negative immediately
after infection (as the WT virus takes over, prior to CTL effects) Growth rates could not be evaluated during the first week because the viral loads at day
0 were below detection (grey rectangle in [C]), but we calculated the difference in growth rates rate from the known percentages in the inoculum. (E)
The variation of escape rate with time is shown for the different animals that were either vaccinated (green symbols) or unvaccinated (purple symbols).
(F) The rate of escape is significantly correlated with the number of KP9 responding CTLs detected by the KP9/Mane-A*10 tetramer.
doi:10.1371/journal.ppat.0040012.g006
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infection would suggest that escape is slower in SIVmac251
infection, and thus that immune selection may be weaker.
However, if one takes into account the timing of escape, the
rate of selection during the second month of infection was
remarkably similar between SHIV and SIVmac251 infections
(compare open blue circles with green / orange circles), and in
fact escape may even have been faster in SIVmac251 infection.
Thus, the assumed low escape rate (and presumed low
selection pressure) in SIVmac251 was most likely a factor of
the timing of escape, not indicative of the potential
effectiveness of vaccine-induced responses in controlling
the virus through this epitope.
Our ﬁndings have important implications when trying to
infer immune selection pressure from escape rates. For
example, it has been suggested that the CTL response in
humans is less effective than in macaques, because of the
faster escape rates observed in macaques [33]. However,
escape is invariably observed later in infection in human
studies, due to the unknown date on infection. Even when the
analysis is limited to ‘‘acutely infected’’ humans, this rarely
includes cases where escape is observed around the peak of
viraemia. Thus, given the link between the timing and rate of
escape, it is not surprising that escape appears slower in
humans than macaques, as when escape is observed it is
usually substantially later in infection. Our studies predict
that if samples can be obtained from subjects with acute HIV
infection where escape or reversion begins to occur early,
that the rates of escape and reversion observed will be rapid
(and potentially completely missed if samples are only studied
in chronic infection).
Understanding when and at what rate escape occurs at
different epitopes is complex. Escape may occur late because
the mutations required are rare, or because the EM virus is
only weakly selected once it occurs. The strength of immune
control and the ﬁtness costs of escape mutation have been
suggested as criteria for selection of optimal vaccine epitopes
[34]. However, the present study suggests a note of caution in
interpreting and comparing escape rates between different
infections [33].
Although we describe in this report novel sensitive qRT-
PCR assays to detect minor viral quasispecies, several
limitations of this assay should be noted. First, although our
assay can speciﬁcally discriminate WT from EM viruses, only
the EM virus that the assay was designed for can be
distinguished, and other mutants that may arise will not be
detected, as it is the LNA-Forward primer that drives the
speciﬁcity of this qRT-PCR. Additional qRT-PCRs could be
designed for rarer escape mutations if needed. For example,
we have rarely detected a typically transient mutation with
KP9 at position 9 (P172S) during the evolution of the
canonical K165R escape [11,26]; understanding the relation-
ship between the 2 mutations could be obtained with
additional qRT-PCR assays. With regard to the sensitivity of
this assay, although the greater dynamic range allows for
detection of minor quasispecies, the integrity of the plasma/
RNA sample is critical for accurate quantiﬁcation of the
sample—the plasma/RNA must be stored appropriately with
minimal freeze/thaws to avoid RNA degradation. The
sensitivity of this discriminatory viral load assay could be
further improved by pelleting virions using ultracentrifuga-
tion of larger plasma samples [35].
In summary, we have developed qRT-PCRs to measure the
kinetics of CTL escape and reversion. We show that both the
timing of escape and reversion and prior vaccination
inﬂuence the dynamics of EM viremia. These ﬁndings
facilitate a better understanding of the evolution and ﬁtness
of escape mutant viruses occurring during HIV-1 and SIV
infection.
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Figure 7. Slow Escape during Chronic SIV Infection and Comparison of
Escape Rates across Multiple Viruses
(A) KP9 EM and WT viremia was studied in a naı ¨ve pigtail macaque
(#5175) infected with SIVmac251.
(B) The rate of escape over time at the KP9 epitope following infection
with three different strains of virus: In SHIVmn229 (orange circles are not
vaccinated, purple circles are vaccinated), early reversion is followed by
viral escape. In SHIVSF162P3 infection (green circles), escape occurs early
and the escape rate is fast. In SIVmac251 infection (open blue circles),
escape occurs late and the escape rate is slow.
doi:10.1371/journal.ppat.0040012.g007
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